• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Endovascular thrombectomy improves functional outcomes in adults with basilar-artery occlusions

byGrace YinandKiera Liblik
October 20, 2022
in Cardiology, Emergency, Surgery
Reading Time: 3 mins read
Study explores effects of daily iron supplementation in 2- to 5-year-olds
Share on FacebookShare on Twitter

1. In comparison to the best available medical care, a greater proportion of patients with basilar-artery occlusions achieved good or excellent functional outcomes at 90-days with endovascular thrombectomy. 

2. Endovascular thrombectomy carried a greater incidence of hemorrhage and procedural complications than usual care, although the overall mortality rate was lower in this group.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Moderate-to-severe strokes associated with basilar-artery occlusions carry a significant mortality and morbidity rate. Endovascular thrombectomy is a technique that involves the mechanical removal of the clot under imaging guidance. For some forms of strokes within larger-vessel arteries, endovascular thrombectomy has been successful. However, the utility of this treatment for basilar-artery strokes is unclear. This study compared endovascular thrombectomy against the best available medical care for basilar-artery strokes. It primarily aimed to understand whether there was a difference in functional outcomes or the safety profile of endovascular thrombectomy in comparison to the best available medical care. Results found that a greater proportion of patients with basilar-artery occlusions were able to achieve good or excellent functional outcomes with thrombectomy in comparison to usual care. Thrombectomy also carried a greater risk of intracranial hemorrhage and procedural complications which can lead to death than the best available medical care, although the overall mortality rate of thrombectomy was lower in the intervention group. The generalizability of this study is a significant limitation. Specifically, it is difficult to generalize the results of this study to patients with basilar-artery occlusions treated after 12 hours, those with a mild stroke, and those who are not of Chinese ethnicity. Although further study into the specific benefit-risk profile of endovascular thrombectomy for various populations is required, this study provided evidence of a promising application of thrombectomy for basilar-artery occlusions which can achieve better functional outcomes than the best available medical care alone.

Click here to read the study in NEJM

In-Depth [randomized controlled trial]: This was a randomized, open-label trial evaluating the functional outcome and safety profile of endovascular thrombectomy for the treatment of moderate-to-severe basilar-artery occlusion compared against the best available treatment. Adult patients with a score of greater than ten on the National Institutes of Health Stroke Scale presenting within 12 hours after the estimated time of occlusion were included. Patients with evidence of intracranial hemorrhage on imaging or with limited pre-stroke functional parameters were excluded. In total, 340 patients were assigned in a 2:1 ratio to receive endovascular thrombectomy (n=226) or control (n=114). The primary outcome of interest was a good functional outcome at 90-days as measured through having a modified Rankin scale score between zero and three. Safety outcomes encompassed intracranial hemorrhage, subarachnoid hemorrhage, or intraventricular hemorrhage leading to death observed on imaging between 24-72 hours after initiation of treatment. Results of the primary analysis found that 46% of patients who received thrombectomy were able to achieve good functional outcomes at 90-days, compared to 23% in the control group (adjusted rate ratio, 2.06; 95% Confidence Interval [CI], 0.2-0.4; p<0.001). Results of secondary analysis found that 33% of patients in the thrombectomy group were able to achieve excellent functional outcomes at 90-days in comparison to 11% in the control group (adjusted rate ratio, 3.17; 95% CI, 1.84-5.46). In terms of safety, the thrombectomy group carried a 37% mortality at 90 days, in comparison to 55% in the control group. Significant complications within the thrombectomy group included symptomatic intracranial hemorrhage (n=12), arterial dissection (n=6), and vessel perforation (n=5). Overall, this study demonstrates that endovascular thrombectomy is more effective than best-available medical care at achieving good or excellent functional outcomes. However, it also carries a higher risk of hemorrhage and procedural complications warranting careful consideration of risks and benefits for the individual patient.

RELATED REPORTS

Artificial intelligence (AI)-supported symptom self-assessment led to more appropriate patient care-seeking decisions

Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy

Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: basilar artery occlusionCardiac surgerycardiologyemergencyendovascular thrombectomyfunctional outcomesSurgeryvascular surgery
Previous Post

Wellness Check: Sleep

Next Post

Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists improve diabetes outcomes but are not cost effective

RelatedReports

Artificial Intelligence

Artificial intelligence (AI)-supported symptom self-assessment led to more appropriate patient care-seeking decisions

October 7, 2026
Gastroenterology

Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy

October 6, 2026
Artificial Intelligence

Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow

September 21, 2026
Emergency

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

September 16, 2026
Next Post
Parental debt influences child socioemotional well-being

Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists improve diabetes outcomes but are not cost effective

Comprehensive cardiovascular disease screening does not reduce incidence of death in men aged 65 to 74

Palliative care consultation linked to lower deaths by failed code resuscitation

Auricular acupressure may improve sleep quality in elderly populations

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.